These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
300 related articles for article (PubMed ID: 8971024)
1. Recombinant adenoviruses with large deletions generated by Cre-mediated excision exhibit different biological properties compared with first-generation vectors in vitro and in vivo. Lieber A; He CY; Kirillova I; Kay MA J Virol; 1996 Dec; 70(12):8944-60. PubMed ID: 8971024 [TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo biology of recombinant adenovirus vectors with E1, E1/E2A, or E1/E4 deleted. Lusky M; Christ M; Rittner K; Dieterle A; Dreyer D; Mourot B; Schultz H; Stoeckel F; Pavirani A; Mehtali M J Virol; 1998 Mar; 72(3):2022-32. PubMed ID: 9499056 [TBL] [Abstract][Full Text] [Related]
3. A new type of adenovirus vector that utilizes homologous recombination to achieve tumor-specific replication. Bernt K; Liang M; Ye X; Ni S; Li ZY; Ye SL; Hu F; Lieber A J Virol; 2002 Nov; 76(21):10994-1002. PubMed ID: 12368342 [TBL] [Abstract][Full Text] [Related]
4. Biology of adenovirus vectors with E1 and E4 deletions for liver-directed gene therapy. Gao GP; Yang Y; Wilson JM J Virol; 1996 Dec; 70(12):8934-43. PubMed ID: 8971023 [TBL] [Abstract][Full Text] [Related]
5. Improved adenovirus packaging cell lines to support the growth of replication-defective gene-delivery vectors. Amalfitano A; Begy CR; Chamberlain JS Proc Natl Acad Sci U S A; 1996 Apr; 93(8):3352-6. PubMed ID: 8622940 [TBL] [Abstract][Full Text] [Related]
6. Novel complementation cell lines derived from human lung carcinoma A549 cells support the growth of E1-deleted adenovirus vectors. Imler JL; Chartier C; Dreyer D; Dieterle A; Sainte-Marie M; Faure T; Pavirani A; Mehtali M Gene Ther; 1996 Jan; 3(1):75-84. PubMed ID: 8929914 [TBL] [Abstract][Full Text] [Related]
7. Generation of an adenovirus vector lacking E1, e2a, E3, and all of E4 except open reading frame 3. Gorziglia MI; Lapcevich C; Roy S; Kang Q; Kadan M; Wu V; Pechan P; Kaleko M J Virol; 1999 Jul; 73(7):6048-55. PubMed ID: 10364357 [TBL] [Abstract][Full Text] [Related]
8. Designing E1 deleted adenoviral vector by homologous recombination. Zamani A; Ghannad MS Iran Biomed J; 2007 Jul; 11(3):199-202. PubMed ID: 18051781 [TBL] [Abstract][Full Text] [Related]
10. Protease-deleted adenovirus vectors and complementing cell lines: potential applications of single-round replication mutants for vaccination and gene therapy. Oualikene W; Lamoureux L; Weber JM; Massie B Hum Gene Ther; 2000 Jun; 11(9):1341-53. PubMed ID: 10890743 [TBL] [Abstract][Full Text] [Related]
11. Generation and characterization of E1/E2a/E3/E4-deficient adenoviral vectors encoding human factor VIII. Andrews JL; Kadan MJ; Gorziglia MI; Kaleko M; Connelly S Mol Ther; 2001 Mar; 3(3):329-36. PubMed ID: 11273775 [TBL] [Abstract][Full Text] [Related]
12. A Cre-expressing cell line and an E1/E2a double-deleted virus for preparation of helper-dependent adenovirus vector. Zhou H; Zhao T; Pastore L; Nageh M; Zheng W; Rao XM; Beaudet AL Mol Ther; 2001 Apr; 3(4):613-22. PubMed ID: 11319924 [TBL] [Abstract][Full Text] [Related]
13. Characterization of 911: a new helper cell line for the titration and propagation of early region 1-deleted adenoviral vectors. Fallaux FJ; Kranenburg O; Cramer SJ; Houweling A; Van Ormondt H; Hoeben RC; Van Der Eb AJ Hum Gene Ther; 1996 Jan; 7(2):215-22. PubMed ID: 8788172 [TBL] [Abstract][Full Text] [Related]
14. Molecular characterization of replication-competent variants of adenovirus vectors and genome modifications to prevent their occurrence. Hehir KM; Armentano D; Cardoza LM; Choquette TL; Berthelette PB; White GA; Couture LA; Everton MB; Keegan J; Martin JM; Pratt DA; Smith MP; Smith AE; Wadsworth SC J Virol; 1996 Dec; 70(12):8459-67. PubMed ID: 8970968 [TBL] [Abstract][Full Text] [Related]
15. Efficient generation of double heterologous promoter controlled oncolytic adenovirus vectors by a single homologous recombination step in Escherichia coli. Hoffmann D; Wildner O BMC Biotechnol; 2006 Aug; 6():36. PubMed ID: 16887042 [TBL] [Abstract][Full Text] [Related]
16. Development of cell lines capable of complementing E1, E4, and protein IX defective adenovirus type 5 mutants. Krougliak V; Graham FL Hum Gene Ther; 1995 Dec; 6(12):1575-86. PubMed ID: 8664382 [TBL] [Abstract][Full Text] [Related]
17. Characterization of human adenovirus 35 and derivation of complex vectors. McVey D; Zuber M; Ettyreddy D; Reiter CD; Brough DE; Nabel GJ; King CR; Gall JG Virol J; 2010 Oct; 7():276. PubMed ID: 20959004 [TBL] [Abstract][Full Text] [Related]
18. Construction of adenovirus vectors through Cre-lox recombination. Hardy S; Kitamura M; Harris-Stansil T; Dai Y; Phipps ML J Virol; 1997 Mar; 71(3):1842-9. PubMed ID: 9032314 [TBL] [Abstract][Full Text] [Related]
19. A gene transfer vector-cell line system for complete functional complementation of adenovirus early regions E1 and E4. Brough DE; Lizonova A; Hsu C; Kulesa VA; Kovesdi I J Virol; 1996 Sep; 70(9):6497-501. PubMed ID: 8709289 [TBL] [Abstract][Full Text] [Related]
20. A replication-incompetent adenovirus vector with the preterminal protein gene deleted efficiently transduces mouse ears. Moorhead JW; Clayton GH; Smith RL; Schaack J J Virol; 1999 Feb; 73(2):1046-53. PubMed ID: 9882305 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]